EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men

Je Hyun Seo, Jung-Min Koh, Han Jin Cho, Hanjun Kim, Young-Sun Lee, Su Jung Kim, Pil Whan Yoon, Won Kim, Sung Jin Bae, Hong-Kyu Kim, Hyun Ju Yoo, Seung Hun Lee

Endocrinology and Metabolism · 2025

DOI: 10.3803/enm.2024.2117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Je Hyun Seo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Korea. Hauptthemen laut MEDLINE: Sarcopenia, Biomarkers, Carnitine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, Ministry of Science and ICT, Ministry of Trade, Industry and Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia, a multifactorial disorder involving metabolic disturbance, suggests potential for metabolite biomarkers. Carnitine (CN), essential for skeletal muscle energy metabolism, may be a candidate biomarker. We investigated whether CN metabolites are biomarkers for sarcopenia.

Methods

Associations between the CN metabolites identified from an animal model of sarcopenia and muscle cells and sarcopenia status were evaluated in men from an age-matched discovery (72 cases, 72 controls) and a validation (21 cases, 47 controls) cohort.

Results

An association between CN metabolites and sarcopenia showed in mouse and cell studies. In the discovery cohort, plasma C5-CN levels were lower in sarcopenic men (P=0.005). C5-CN levels in men tended to be associated with handgrip strength (HGS) (P=0.098) and were significantly associated with skeletal muscle mass (P=0.003). Each standard deviation increase in C5-CN levels reduced the odds of low muscle mass (odd ratio, 0.61; 95% confidence interval [CI], 0.42 to 0.89). The area under the receiver operating characteristic curve (AUROC) of CN score using a regression equation of C5-CN levels, for sarcopenia was 0.635 (95% CI, 0.544 to 0.726). In the discovery cohort, addition of CN score to HGS significantly improved AUROC from 0.646 (95% CI, 0.575 to 0.717; HGS only) to 0.727 (95% CI, 0.643 to 0.810; P=0.006; HGS+CN score). The improvement was confirmed in the validation cohort (AUROC=0.563; 95% CI, 0.470 to 0.656 for HGS; and AUROC=0.712; 95% CI, 0.569 to 0.855 for HGS+CN score; P=0.027).

Conclusion

C5-CN, indicative of low muscle mass, is a potential circulating biomarker for sarcopenia in men. Further studies are required to confirm these results and explore sarcopenia-related metabolomic changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaBiomarkersCarnitineHumansMaleAgedMuscle, SkeletalMiddle AgedMiceAnimalsHand StrengthCase-Control StudiesCohort StudiesAged, 80 and over

Stichwörter der Autor:innen

AgingBiomarkersCarnitineMetabolomicsSarcopenia

Substanzen

BiomarkersCarnitine

Autor:innen und Institutionen

  • Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
  • Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
  • Department of Orthopedic Surgery, Seoul Now Hospital, Anyang, Korea.
  • Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center
  • Ministry of Science and ICT
  • Ministry of Trade, Industry and Energy
  • Ministry of Health and Welfare
  • National Research Foundation of Korea

Zitieren

APA

Seo, J. H., Koh, J. M., Cho, H. J., Kim, H., Lee, Y. S., Kim, S. J., Yoon, P. W., Kim, W., Bae, S. J., Kim, H. K., Yoo, H. J., & Lee, S. H. (2025). Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2024.2117

Vancouver

Seo JH, Koh JM, Cho HJ, Kim H, Lee YS, Kim SJ, et al. Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2024.2117

BibTeX
@article{Seo2025,
  author = {Seo, Je Hyun and Koh, Jung-Min and Cho, Han Jin and Kim, Hanjun and Lee, Young-Sun and Kim, Su Jung and Yoon, Pil Whan and Kim, Won and Bae, Sung Jin and Kim, Hong-Kyu and Yoo, Hyun Ju and Lee, Seung Hun},
  title = {Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  doi = {10.3803/enm.2024.2117}
}
Kostenlos starten →